These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34058194)

  • 1. An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice.
    Ge W; Zhao Y; Yang Y; Ding Z; Xu X; Weng D; Wang S; Cheng R; Zhang J
    J Biol Chem; 2021 Jul; 297(1):100846. PubMed ID: 34058194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
    Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
    Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats.
    Cho HM; Seok YM; Lee HA; Song M; Kim I
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
    Goyal N; Tiwary S; Kesharwani D; Datta M
    J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
    Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
    Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1.
    Wang S; Ai H; Liu L; Zhang X; Gao F; Zheng L; Yi J; Sun L; Yu C; Zhao H; Li Y
    Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E911-E924. PubMed ID: 31526292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
    Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.
    Yan H; Yang W; Zhou F; Li X; Pan Q; Shen Z; Han G; Newell-Fugate A; Tian Y; Majeti R; Liu W; Xu Y; Wu C; Allred K; Allred C; Sun Y; Guo S
    Diabetes; 2019 Feb; 68(2):291-304. PubMed ID: 30487265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
    Pan Q; Ai W; Chen Y; Kim DM; Shen Z; Yang W; Jiang W; Sun Y; Safe S; Guo S
    Diabetes; 2023 Sep; 72(9):1193-1206. PubMed ID: 37343276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
    Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
    J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
    Tian F; Ying HM; Wang YY; Cheng BN; Chen J
    Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
    Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
    Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding.
    Jang H; Lee GY; Selby CP; Lee G; Jeon YG; Lee JH; Cheng KK; Titchenell P; Birnbaum MJ; Xu A; Sancar A; Kim JB
    Nat Commun; 2016 Jul; 7():12180. PubMed ID: 27412556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red Pepper (
    Kim HK; Jeong J; Kang EY; Go GW
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32842462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin F
    Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
    Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liver.
    Oh KJ; Park J; Kim SS; Oh H; Choi CS; Koo SH
    PLoS Genet; 2012 Sep; 8(9):e1002986. PubMed ID: 23028378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A crucial role of adenosine deaminase in regulating gluconeogenesis in mice.
    Ding Z; Ge W; Xu X; Xu X; Sun Q; Xu X; Zhang J
    J Biol Chem; 2024 Jul; 300(7):107425. PubMed ID: 38823639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.
    Qu S; Altomonte J; Perdomo G; He J; Fan Y; Kamagate A; Meseck M; Dong HH
    Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA sequencing of db/db mice liver identifies lncRNA H19 as a key regulator of gluconeogenesis and hepatic glucose output.
    Goyal N; Sivadas A; Shamsudheen KV; Jayarajan R; Verma A; Sivasubbu S; Scaria V; Datta M
    Sci Rep; 2017 Aug; 7(1):8312. PubMed ID: 28814771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.